Quarterly Report • Oct 25, 2023
Quarterly Report
Open in ViewerOpens in native device viewer

No significant events took place after the end of the period.
In the third quarter, net sales grew, we reported the highest operating margin since our IPO in 2021, and the number of subscriptions increased compared to the previous quarter. The positive development confirms that we have a successful strategy with a focus on cost-effective user acquisition and increased conversion rate. The operating margin for the third quarter was 33.5% (24.7%).
The number of users decreased slightly compared to the same period of the prior year (-2.8%), but at the same time the total number of users increased for the first time since prices were adjusted in 2022. This confirms that the negative trend from the previous quarters has been broken. Revenue grew by 11.1% (12.8%), an increase related mainly to ARPU, which increased due to positive currency effects and price increases. Given that the number of subscribers grew during the quarter, and that we see strong momentum, my view is that we will see positive effects on the underlying growth going forward, in addition to effects from ARPU.
The efficiency initiative launched in the second quarter of 2023 has delivered the desired results, and is expected to generate savings of SEK 25 million on an annual basis. This initiative is enabling us to strengthen our focus on development of the core product while freeing up additional resources in the company at the same time. In the third quarter, we have therefore been able to focus on creating even stronger and more dynamic onboarding for new users, which has resulted in cost-effective growth in the form of a higher conversion rate to our Premium offering.
We are continuing to invest in innovation and new functions in order to be able to bring our users even deeper insights into their sleep and health. All for the purpose of contributing to a healthier world. Over the year we have, for example, developed a stronger data processing engine
that will be able to generate even better and more accurate analyses. Next quarter, built on the basis of the new AI engine, we will launch a beta version of a new service capable of providing local updates on the development of colds in different geographical regions. This is made possible by the power of AI and machine learning combined with more than 2.5 billion nights of sleep data. This feature analyzes Sleep Cycle data of sleep, coughing, breathing, and snoring on a larger population, which will provide unique insights into the health status of a specific region.
Innovation is - and has always been - at the core of our business. We strive to stay ahead of the curve and offer our users the best possible experience. During the quarter, we have worked closely with Apple and Google to increase exposure and make more powerful use of the platforms on which we are available. Through strong collaboration, we were able to quickly launch new features that leverage the benefits of iOS 17, which was made available when Apple released the new iPhone 15.
It feels very positive that in tough economic times we have managed to increase our operating margin and at the same time create growth in the user base. This shows that we have successfully implemented a more focused and businessdriven strategy. I am looking forward to an exciting period with several launches of new features to bring us closer to the goal of helping people achieve better sleep. I also look forward to welcoming our new CEO, Erik Jivmark, who will be starting on November 1. Together with him and the rest of the team, we will continue to develop Sleep Cycle, work to create new business opportunities and to grow our business going forward.

Per Andersson Acting CEO and CFO

Sleep Cycle is a leader in the development of AI-based sleep analysis. With more than two million users in more than 150 countries, Sleep Cycle is one of the most widely used sleep services in the world.
Our business is based on a subscription-based business model that creates predictability and a strong cash flow through advance payments and recurring revenues. Because we offer an appreciated product built on many years of development, and where customer influx is largely organic, our customer acquisition costs are low, resulting in attractive profitability. Combined with the fact that the cost of each new user is very low, our business is fully scalable.
AI and machine learning have revolutionized our ability to manage large amounts of data and extract valuable information. The application of advanced algorithms and techniques allows us to extract patterns and contexts that were previously unknown and inaccessible.
Sleep Cycle analyzes audio that, using a database of more than two billion nights, gives users individual insights, advice, and recommendations about their sleep. The fact that the analysis is sound-based also makes it possible to capture snoring, coughing, tooth grinding, and other sounds that disrupt sleep and can provide additional health insights in a broader perspective.
The future of sleep optimization offers expansive opportunities in both product development and accessibility of our services on more platforms and in new channels. With a nearly unrivaled volume of sleep data, patented sleep analysis, and a large user base, we are in a very strong position to develop new and innovative services for sleep analysis.
Through continuous product development, Sleep Cycle continues to add new features for analysis of sleep, snoring, sleep hygiene, and coaching tools to help our users achieve better health. Future plans also include bringing out functions for optimizing health, sleep and well-being as well as functions to detect clinical sleep problems such as insomnia and sleep apnea.
23:49 05:17
Worked o;t
Com5are yo;rXelf to: Sweden
StreXXf;l day Bath
Early dinner Coffee
01:12 Slee5 talkin
81%
M T W T F S S
Slee5 Awake
04:41 Snorin .me*
7h 2min
Time in bed You spent on average 7h and 2mins in bed. This is a -6 minute difference since last week. The average Swede spent 6h and 46min in bed last week.
02:42 Co; hin

Stop 06:47
Good morning! Snooze


Sleep Cycle's strategy for the coming year is to increase investments in data, AI, and product development to reach more users, create greater value for users, and achieve growth through new acquisition channels.
The value and strength of the Sleep Cycle increase night by night. Using patented audio analytics, we collect and analyze sleep data, which we then translate into insights for users around the world. With each new user, our database grows; with each night read, our analytical capabilities sharpen; and with each analysis, we generate even more valuable insights and develop new cuttingedge tools.
To achieve our goals, our focus is on broadening the range of services and increasing accessibility. We have to be present on platforms where our target groups are and where our unique expertise and interest in sleep creates value.

New data-driven features that provider users more insights into sleep and health.
SLEEP ANALYSIS
HEALTH MONITORING
INFLUENZA SYMPTOMS
SNORING
BREATHING PAUSES
TOOTH GRINDING

Reaching new users through new platforms, partnerships, and channels.
PARTNERSHIP
MORE PLATFORMS
NEW HARDWARE
As all significant operations in the Group are conducted in the Parent Company, the comments below refer to both the Parent Company and the Group. For profit and cash flow, comparative figures refer to the corresponding period for prior year. For financial position, comparative figures refer to the balance sheet item as of December 31, 2022.
The Group's net sales during the third quarter totaled tSEK 61,065 (54,976), which is an increase of 11.1% (12.8%) compared with prior year. The increase in net sales is due primarily to positive currency effects and higher ARPU. Currency-adjusted net sales growth amounted to 2.6% (7.3%). Average revenue per user (ARPU) increased by 15.5% and amounted to SEK 276 (239). In addition to exchange rate effects, ARPU was positively affected by the price increases introduced in the previous year.
The number of paying users totaled 887k (912k). The decrease in the total number of users is explained by a reduction in the number of users in the previous quarter as a result of a weaker market with fewer downloads. The negative trend from the previous quarter was broken during the third quarter, and the number of paying users increased by 10k compared to the second quarter. The increase is explained by a combination of higher conversion rate and a stable number of downloads.
Operating profit totaled tSEK 20,427 (13,563) and the margin 33.5% (24.7%) in the third quarter. The improved margin is a result of the efficiency program for increased profitability and continued growth that was communicated during the second quarter. The measures were almost fully implemented during the third quarter, which has had a positive impact on the cost level and margin. The total savings
are estimated to amount to about SEK 25 million on a full-year basis, involving a reduction in the number of employees, reduced purchases of external services, and scaling back of marketing investments. The reduction of these costs explains the improved margin compared to prior year, although personnel expenses increased as a result of costs related to the change of CEO, which were fully recorded during the period. Costs for employee terminations as part of the efficiency program were charged to the second quarter, although several individuals remained employed in the third quarter as a result of notice periods.
Adjusted operating profit totaled tSEK 20,427 (13,563) and adjusted margin was 33.5% (24.7%). The third quarter of 2023 has not been affected by costs affecting comparability.
Net financial items for the quarter totaled tSEK 474 (-41) and taxes on profit for the quarter totaled tSEK -4,324 (-2,793). Profit for the quarter totaled tSEK 16,577 (10,729). Earnings per share before dilution amounted to SEK 0.82 (0.55) and after dilution SEK 0.82 (0.54).
Cash flow from operating activities in the third quarter totaled tSEK 15,265 tSEK (6,344). The change in cash flow from operating activities is explained mainly by improved profits. Cash flow from investment activities amounted to tSEK -1,020 (-1,828) related to capitalized
development expenses and acquisitions of tangible fixed assets.
Cash flow from financing activities for the quarter totaled tSEK -1,004 (15,780). The change is due to the new issue in August of 2022, which brought the company tSEK 16,538 after deduction of transaction costs that took place after conversion of the share warrant program 2019/2022 that expired.
Cash flow for the quarter totaled tSEK 13,240 (20,296). The group's liquid funds at the end of the period totaled tSEK 117,956 (222,811).
Consolidated equity totaled tSEK 54,854 as of 30 September. Opening balance on January 1 was tSEK 160,834.
Changes in net sales, profit, cash flow and financial position for the nine-month period of 2023 compared with the previous year are largely explained by the same reasons as for the third quarter. Development over a nine-month period is indicated below, with comments in cases where there are causes for development other than for the third quarter.
The Group's net sales for the period totaled tSEK 175,745 (157,569), which is an increase of 11.5% (16.8%) compared with prior year. Currencyadjusted net sales growth was 2.2% (14.4%).
Operating profit totaled tSEK 44,251 (39,099) and the margin was 25.2% (24.8%) for the period. Adjusted operating profit totaled tSEK 49,082 (39,099) and the adjusted margin was 27.9% (24.8%). The item other external costs includes costs affecting comparability of tSEK 298 related to the public cash offer in 2022. Furthermore, tSEK 83 is included in other external costs and tSEK 4,450 in personnel costs related to the efficiency program implemented in the second quarter.
Net financial items for the period totaled tSEK 1,111 (-100) and taxes on the profit for the period totaled tSEK -9,399 (-8 075). Profit for the period totaled tSEK 35,963 (30,924). Earnings per share before dilution amounted to SEK 1.77 (1.59) and after dilution SEK 1.77 (1.55).
Cash flow from operating activities for the period totaled tSEK 36,294 (48,008). The change in cash flow from operating activities reflects payments from Apple that do not follow monthly payments and negatively affects working capital. The cash flow is negatively affected as accounts receivables increases, reflecting a longer period and is thus higher as per closing day, without being overdue. Payment is received in the next period.
Cash flow from investment activities amounted to tSEK -6,626 (-4,929) related to capitalized development expenses and acquisitions of tangible fixed assets.
Cash flow from financing activities totaled tSEK -144,574 (14,635) and mainly pertains to amortization of leasing liabilities and dividends paid in 2023. The change in comparison with prior year is due to the dividend paid out.
Cash flow for the period totaled tSEK -114,906 tSEK (57,714). The group's liquid funds at the end of the period totaled tSEK 117,956 (222,811).
Consolidated equity totaled tSEK 54,854 as of 30 September. Opening balance on January 1 was tSEK 160,834.
The average number of employees in the Group for the quarter from July to September 2023 was 45 (47) and for the period from January to June 2023 was 48 (46). The number of employees after cuts related to the efficiency program was 39, but because of notice periods, several individuals remained employed during the third quarter, although the costs for these were charged to the second quarter.
The group's over-arching risk management aims to minimize negative effects on profit and position. Significant risks and uncertainties are described in the annual report for 2022. No significant events have occurred during the period that affect or change the descriptions of the Group's risks and their management.
The Group's operations are essentially conducted in the parent company, which is why reference is made to the information above for the Group.
There have been no related-party transactions aside from remuneration with senior executives in their capacity as such.
This report has not undergone a review engagement by the Company's auditors.
On October 25, at 9:30 a.m., there will be a presentation of Sleep Cycle's interim report for July-September 2023 for shareholders, media, and other stakeholders. Participants will be able to follow the presentation via a webcast.
The company's share has been listed on Nasdaq Stockholm under the ticker SLEEP since June 8, 2021. Share capital on the balance sheet date totaled tSEK 563.
| Option program | Number of options |
Corresponding number of shares |
Percentage of total number of shares |
Exercise price |
Redemption period |
|---|---|---|---|---|---|
| TO 2020 | 1,225 | 147,000 | 0.7% | 88.9 | 2023 |
| TO 2021 series 1 | 190,076 | 190,076 | 0.9% | 94.5 | 2024 |
| TO 2021 series 2 | 18,595 | 18,595 | 0.1% | 94.5 | 2025 |
| TO 2022 | 54,820 | 54,820 | 0.3% | 71.2 | 2025 |
| CEO LTIP | 340,909 | 340,909 | 1.7% | 241.2 | 2026 |
| Total | 605,625 | 751,400 | 3.7% |
| Owner | Number of shares | Votes and capital |
|---|---|---|
| Maciek Drejak through company | 8,707,984 | 42.9% |
| Pierre Siri through company | 4,776,686 | 23.6% |
| Avanza Pension | 899,072 | 4.4% |
| Handelsbanken Microcap | 728,837 | 3.6% |
| Skandia Fonder | 714,285 | 3.5% |
| Petter Wallin | 691,394 | 3.4% |
| Nordnet Pensionsförsäkring | 665,267 | 3.3% |
| Lancelot Avalon | 429,086 | 2.1% |
| Cancerfonden | 291,882 | 1.4% |
| SEB Nanocap | 220,000 | 1.1% |
| Other | 2,153,070 | 10.6% |
| Total | 20,277,563 | 100% |
| Jul - Sep | Jan - Sep | Jan - Dec | |||
|---|---|---|---|---|---|
| tSEK Note |
2023 | 2022 | 2023 | 2022 | 2022 |
| OPERATING INCOME | |||||
| Net sales 4 |
61,065 | 54,976 | 175,745 | 157,569 | 213,271 |
| Other operating income | 38 | 86 | 105 | 483 | 529 |
| OPERATING EXPENSES | |||||
| Capitalized work for own account | 69 | 498 | 1,098 | 2,299 | 3,224 |
| Platform fees | -13,727 | -12,644 | -39,403 | -36,908 | -49,741 |
| Other external expenses | -10,809 | -15,255 | -39,981 | -40,699 | -63,383 |
| Personnel expenses | -13,844 | -12,574 | -46,814 | -39,432 | -54,201 |
| Depreciation and impairment of tangible and intangible assets |
-2,302 | -1,380 | -6,205 | -3,983 | -5,261 |
| Other operating expenses | -63 | -143 | -293 | -230 | -329 |
| Operating profit/loss | 20,427 | 13,563 | 44,251 | 39,099 | 44,110 |
| FINANCIAL ITEMS | |||||
| Financial income | 668 | - | 1,540 | 1 | 157 |
| Financial expenses | -194 | -41 | -429 | -101 | -137 |
| Profit before tax | 20,902 | 13,522 | 45,362 | 38,999 | 44,130 |
| Tax on profit for the period | -4,324 | -2,793 | -9,399 | -8,075 | -9,155 |
| Profit for the period attributable to the parent company's shareholders |
16,577 | 10,729 | 35,963 | 30,924 | 34,976 |
| Other comprehensive income | - | - | - | - | - |
| Comprehensive income for the period attributable to the parent company's shareholders |
16,577 | 10,729 | 35,963 | 30,924 | 34,976 |
| Earnings per share before dilution, SEK | 0.82 | 0.55 | 1.77 | 1.59 | 1.77 |
| Earnings per share after dilution, SEK | 0.82 | 0.54 | 1.77 | 1.55 | 1.74 |
| Average number of shares outstanding for the period before dilution |
20,277,203 | 19,427,535 | 20,277,203 | 19,427,535 | 19,729,788 |
| Average number of shares outstanding for the period after dilution |
20,277,203 | 20,038,358 | 20,277,203 | 19,981,887 | 20,056,591 |
| tSEK Note |
09/30/2023 | 09/30/2022 | 12/31/2022 |
|---|---|---|---|
| ASSETS | |||
| Intangible fixed assets | |||
| Capitalized expenses for development work | 11,650 | 7,411 | 9,595 |
| Patent | - | - | - |
| Total intangible fixed assets | 11,650 | 7,411 | 9,595 |
| Tangible fixed assets | |||
| Right-of-use assets | 16,691 | 4,772 | 4,132 |
| Cost of improvement on other's property | 781 | - | - |
| Equipment and computers | 1,864 | 1,451 | 1,468 |
| Total tangible fixed assets | 19,336 | 6,223 | 5,601 |
| Financial assets | |||
| Other long-term receivables | 411 | 411 | 411 |
| Total financial assets | 411 | 411 | 411 |
| Deferred tax | |||
| Deferred prepaid tax | 50 | 50 | 13 |
| Total deferred tax | 50 | 50 | 13 |
| Current assets | |||
| Accounts receivable | 34,131 | 19,975 | 22,388 |
| Other receivables | 666 | 552 | 1,084 |
| Current tax assets | 1,714 | 4,033 | 1,474 |
| Prepaid expenses and accrued income | 31,450 | 27,291 | 27,943 |
| Cash and cash equivalents | 117,956 | 222,811 | 232,862 |
| Total current assets | 185,917 | 274,663 | 285,751 |
| TOTAL ASSETS | 217,364 | 288,757 | 301,371 |
| EQUITY AND LIABILITIES | |||
| Equity | |||
| Share capital | 563 | 563 | 563 |
| Other contributed capital | - | 119,229 | 119,229 |
| Retained earnings, including profit for the year | 54,291 | 36,991 | 41,042 |
| Total equity attributable to the parent company's shareholders |
54,854 | 156,783 | 160,834 |
| Long-term liabilities | |||
| Leasing liabilities | 12,804 | 2,939 | 2,623 |
| Total long-term liabilities | 12,804 | 2,939 | 2,623 |
| Current liabilities | |||
| Leasing liabilities | 4,129 | 1,886 | 1,572 |
| Accounts payable | 13,530 | 11,709 | 14,203 |
| Other liabilities | 5,106 | 3,050 | 2,889 |
| Accrued expenses and deferred income | 126,940 | 112,391 | 119,250 |
| Total current liabilities | 149,706 | 129,035 | 137,914 |
| TOTAL EQUITY AND LIABILITIES | 217,364 | 288,757 | 301,371 |
| Attributable to the parent company's shareholders | |||
|---|---|---|---|
| 09/30/2023 | 09/30/2022 | 12/31/2022 | |
| 160,834 | 108,898 | 108,898 | |
| 35,963 | 30,924 | 34,976 | |
| -141,943 | - | - | |
| - | 368 | 368 | |
| - | 16,593 | 16,593 | |
| 54,854 | 156,783 | 160,834 | |
| Jul - Sep | Jan - Sep | Jan - Dec | |||
|---|---|---|---|---|---|
| tSEK Note |
2023 | 2022 | 2023 | 2022 | 2022 |
| Cash flow from operating activities | |||||
| Operating profit/loss | 20,427 | 13,563 | 44,251 | 39,099 | 44,110 |
| Adjustments for items not included in cash flow: | |||||
| Depreciation and impairment | 2,302 | 1,380 | 6,205 | 3,983 | 5,261 |
| Interest received | 668 | - | 1,540 | 1 | 157 |
| Interest paid | -194 | -41 | -429 | -101 | -137 |
| Tax paid | -3,032 | -2,994 | -9,676 | -7,042 | -5,525 |
| Cash flow from operating activities before changes in working capital |
20,172 | 11,908 | 41,891 | 35,940 | 43,866 |
| Change in working capital | |||||
| Change in operating receivables | -3,449 | -1,848 | -14,832 | 1,288 | -2,309 |
| Change in operating liabilities | -1,458 | -3,717 | 9,235 | 10,779 | 19,971 |
| Cash flow from operating activities | 15,265 | 6,344 | 36,294 | 48,008 | 61,528 |
| Investment activities | |||||
| Capitalization of development expenses | -992 | -1,451 | -4,899 | -4,216 | -6,917 |
| Acquisition of tangible fixed assets | -28 | -378 | -1,727 | -713 | -852 |
| Cash flow from investment activities | -1,020 | -1,828 | -6,626 | -4,929 | -7,769 |
| Financing activities | |||||
| Repayment of leasing liabilities | -1,004 | -758 | -2,632 | -2,270 | -2,899 |
| Option premiums repaid | - | - | - | -11 | -11 |
| Option premiums received | - | - | - | 378 | 378 |
| Dividend | - | - | -141,943 | - | - |
| New share issues | - | 16,538 | - | 16,538 | 16,538 |
| Cash flow from financing activities | -1,004 | 15,780 | -144,574 | 14,635 | 14,006 |
| Cash flow for the period | 13,240 | 20,296 | -114,906 | 57,714 | 67,765 |
| Liquid funds at the beginning of the period | 104,716 | 202,515 | 232,862 | 165,508 | 165,508 |
| Reclassification of cash and cash equivalents | - | - | - | -411 | -411 |
| Liquid funds at the end of the period | 117,956 | 222,811 | 117,956 | 222,811 | 232,862 |
| Jul - Sep | Jan - Sep | Jan - Dec | |||
|---|---|---|---|---|---|
| tSEK Note |
2023 | 2022 | 2023 | 2022 | 2022 |
| OPERATING INCOME | |||||
| Net sales | 61,065 | 54,976 | 175,745 | 157,569 | 213,271 |
| Other operating income | 38 | 86 | 105 | 483 | 529 |
| Capitalized work for own account | 69 | 498 | 1,098 | 2,299 | 3,224 |
| OPERATING EXPENSES | |||||
| Platform fees | -13,727 | -12,644 | -39,403 | -36,908 | -49,741 |
| Other external expenses | -12,007 | -16,054 | -43,035 | -43,065 | -66,413 |
| Personnel expenses | -13,844 | -12,574 | -46,814 | -39,432 | -54,201 |
| Depreciation and impairment of tangible and intangible assets |
-1,216 | -616 | -3,394 | -1,702 | -2,340 |
| Other operating expenses | 63 | -143 | -293 | -230 | -329 |
| Operating profit/loss | 20,315 | 13,528 | 44,010 | 39,014 | 44,000 |
| PROFIT FROM FINANCIAL ITEMS | |||||
| Interest income and similar income | 668 | - | 1,540 | 1 | 157 |
| Profit before tax | 20,984 | 13,528 | 45,550 | 39,015 | 44,158 |
| Tax on profit for the period | -4,341 | -2,795 | -9,436 | -8,077 | -9,159 |
| Profit/loss for the period | 16,643 | 10,734 | 36,114 | 30,938 | 34,999 |
| COMPREHENSIVE INCOME FOR THE PERIOD | 16,643 | 10,734 | 36,114 | 30,938 | 34,999 |
Since the parent company has no items recognized as other comprehensive income, total comprehensive income for the period is equal to profit for the period.
| tSEK Note |
09/30/2023 | 09/30/2022 | 12/31/2022 |
|---|---|---|---|
| ASSETS | |||
| Fixed assets | |||
| Intangible fixed assets | |||
| Capitalized expenses for development work | 11,650 | 7,411 | 9,595 |
| Patent | - | - | - |
| Total intangible fixed assets | 11,650 | 7,411 | 9,595 |
| Tangible fixed assets | |||
| Cost of improvement on other's property | 781 | - | - |
| Equipment and computers | 1,864 | 1,451 | 1,468 |
| Total tangible fixed assets | 2,645 | 1,451 | 1,468 |
| Financial assets | |||
| Participations in group companies | 50 | 50 | 50 |
| Deferred prepaid tax | - | 39 | - |
| Other long-term receivables | 411 | 411 | 411 |
| Total financial assets | 461 | 500 | 461 |
| Total fixed assets | 14,757 | 9,361 | 11,524 |
| Current assets | |||
| Current receivables | |||
| Accounts receivable | 34,131 | 19,975 | 22,388 |
| Other receivables | 666 | 552 | 1,084 |
| Current tax assets | 1,714 | 4,033 | 1,474 |
| Prepaid expenses and accrued income | 31,450 | 27,291 | 27,943 |
| Total current receivables | 67,961 | 51,852 | 52,889 |
| Short-term investments | |||
| Other short-term investments | 85,000 | - | - |
| Total short-term investments | 85,000 | - | - |
| Cash and bank balances | 32,848 | 222,694 | 232,746 |
| Total current assets | 185,809 | 274,546 | 285,635 |
| TOTAL ASSETS | 200,566 | 283,907 | 297,160 |
| EQUITY AND LIABILITIES | |||
| Equity | |||
| Restricted equity | |||
| Share capital | 563 | 563 | 563 |
| Fund for development expenditures | 11,650 | 7,411 | 9,595 |
| Total restricted equity | 12,213 | 7,974 | 10,158 |
| Unrestricted equity | |||
| Share premium fund | - | 119,229 | 119,229 |
| Retained earnings | 6,662 | -1,383 | -3,568 |
| Profit/loss for the period | 36,114 | 30,938 | 34,999 |
| Total unrestricted equity | 42,776 | 148,784 | 150,660 |
| Total equity | 54,989 | 156,758 | 160,818 |
| Current liabilities | |||
| Accounts payable | 13,530 | 11,709 | 14,203 |
| Other liabilities | 5,106 | 3,050 | 2,889 |
| Accrued expenses and deferred income | 126,940 | 112,391 | 119,250 |
| Total current liabilities | 145,576 | 127,150 | 136,341 |
| TOTAL EQUITY AND LIABILITIES | 200,566 | 283,907 | 297,160 |
The address of the company's registered office is Drakegata 10, 412 50 Gothenburg, Sweden. Sleep Cycle is developing of one of the world's most widely used sleep platforms. Sleep Cycle's sleep solutions help users fall asleep more easily, measure sleep habits and improve sleep and with the extensive sleep database contribute to improved sleep habits and increased sleep awareness worldwide. The business is essentially conducted in the parent company. The parent company's holding of shares in group companies as of September 30, 2023 consists of the wholly owned subsidiary Sleep Cycle Sverige AB (559278–9688).
Sleep Cycle's interim report for Jan-Sep 2023 was approved for publication on October 25 per Board decision on October 24, 2023.
The consolidated financial statement for Sleep Cycle AB has been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the EU, the Swedish Annual Accounts Act (ÅRL) and the Swedish Financial Reporting Board's RFR 1 "Supplementary accounting rules for groups". The parent company's financial reports have been prepared in accordance
with the Annual Accounts Act and RFR 2, "Accounting for Legal Entities."
This interim report has been prepared in accordance with IAS 34 "Interim Financial Reporting." Disclosures in accordance with IAS 34 are provided in notes as well as elsewhere in the interim report.
The accounting principles and calculation methods applied are in accordance with those described in the annual report for 2022. New standards and interpretations that came into force on 1 January 2023 have not had any effect on the group's or the parent company's financial reports for the interim period.
Sleep Cycle's CEO, as the highest executive decision-maker, follows up and analyzes results and financial position for the Group as a whole. The CEO does not track results at a level lower than the Group as a whole. The CEO thereby also decides on allocation of resources and makes strategic decisions based on the Group as a whole. Based on the above analysis following IFRS 8, it can be seen that the Sleep Cycle Group consists of only one reporting segment.
| Jul - Sep | Jan - Sep | Jan - Dec | ||||
|---|---|---|---|---|---|---|
| tSEK | 2023 | 2022 | 2023 | 2022 | 2022 | |
| Subscription income | 60,908 | 54,716 | 175,272 | 157,046 | 212,534 | |
| Other income | 157 | 261 | 473 | 523 | 737 | |
| Total | 61,065 | 54,976 | 175,745 | 157,569 | 213,271 |
| tSEK | 09/30/2023 | 09/30/2022 | 12/31/2022 |
|---|---|---|---|
| Financial assets valued at amortized cost | |||
| Accounts receivable | 34,131 | 19,975 | 22,388 |
| Other receivables | 1,077 | 963 | 1,496 |
| Accrued income | 259 | 113 | - |
| Cash and cash equivalents | 117,956 | 222,811 | 232,862 |
| Total financial assets | 153,423 | 243,863 | 256,746 |
| Financial liabilities valued at amortized cost | |||
| Leasing liabilities | 18,526 | 5,046 | 4,381 |
| Accounts payable | 13,530 | 11,709 | 14,203 |
| Other current liabilities | 1,815 | 3,391 | 5,849 |
| Total financial liabilities | 33,871 | 20,146 | 24,433 |
Sleep Cycle does not hold any financial instruments that are valued and reported at fair value. For all financial assets and liabilities, the carrying amount is considered as above to be a reasonable approximation of fair value.
Sleep Cycle applies the guidelines for alternative key performance indicators issued by ESMA. This report presents certain financial key performance ratios, including alternative key performance indicators which are not defined under IFRS. The Company considers these key performance indicators an important complement, as they facilitate a better evaluation of the Company's financial trends. These financial key performance indicators should not be assessed independently or considered
replacements for performance indicators that have been calculated in accordance with IFRS. In addition, such key performance indicators, as defined by Sleep Cycle, should not be compared with other key performance indicators with similar names utilized by other companies. This is because the key performance indicators below are not always defined in the same way, and other companies may calculate them differently than Sleep Cycle.
| Key performance indicators | Definition | Background of the use of the key performance indicator |
|---|---|---|
| Net sales growth | Change in net sales compared with the same period of prior year. |
The measure shows the company's growth in net sales compared with the same period of prior year. |
| Currency-adjusted net sales growth |
Defined as the year's net sales divided by prior year's net sales adjusted to the year's average exchange rates for the company's main currency exposures (USD, EUR, JPY, GBP, AUD, and CAD). |
Used to measure the company's underlying net sales growth adjusted for currency effects. |
| Operating profit/loss | Operating profit before interest and tax | Operating profit is used to understand the company's earning capacity |
| Operating margin | Operating profit as a percentage of the company's net sales. |
Operating margin is an indication of the company's earning capacity in relation to net sales. |
| Items affecting comparability |
Non-recurring items not included in normal operations and therefore disrupt comparability between different periods. Refers to costs related to IPO in 2021, public cash offer in 2022, and cost savings in 2023. |
The measure is used to understand the company's development and comparison between the years. |
| Adjusted operating profit/loss |
Operating profit adjusted for items affecting comparability. |
Adjusted operating profit is used to understand the company's earning capacity adjusted for items affecting comparability. |
| Adjusted operating margin | Adjusted operating profit as a percentage of the company's net sales. |
Adjusted operating margin is used to understand the company's earning capacity adjusted for items affecting comparability. |
| Total subscriptions | Total number of subscriptions at the end of the period (closing balance). |
The measure indicates how many subscribers the company has at the end of the period. |
| ARPU | Average annual subscription revenue per subscriber during the period. Quarters and periods are annualized. |
The measure indicates the company's subscription income per subscription on average during the period |
The table below derives from the calculation of alternative key performance indicators not defined in accordance with IFRS or where the calculation is not shown in another table in this report.
| net sales growth | Jul - Sep | Jan - Sep | Jan - Dec | |||
|---|---|---|---|---|---|---|
| tSEK | 2023 | 2022 | 2023 | 2022 | 2022 | |
| Net sales previous period | 54,976 | 48,759 | 157,569 | 134,897 | 182,937 | |
| Net sales current period | 61,065 | 54,976 | 175,745 | 157,569 | 213,271 | |
| Net sales growth | 11.1% | 12.8% | 11.5% | 16.8% | 16.6% | |
| Currency-adjusted net sales previous period | 59,509 | 51,254 | 171,975 | 137,691 | 189,743 | |
| Net sales current period | 61,065 | 54,976 | 175,745 | 157,569 | 213,271 | |
| Currency-adjusted net sales growth | 2.6% | 7.3% | 2.2% | 14.4% | 12.4% |
| Jul - Sep | Jan - Sep | Jan - Dec | ||||
|---|---|---|---|---|---|---|
| tSEK | 2023 | 2022 | 2023 | 2022 | 2022 | |
| Net sales | 61,065 | 54,976 | 175,745 | 157,569 | 213,271 | |
| Other operating income | 38 | 86 | 105 | 483 | 529 | |
| Capitalized work for own account | 69 | 498 | 1,098 | 2,299 | 3,224 | |
| Platform fees | -13,727 | -12,644 | -39,403 | -36,908 | -49,741 | |
| Other external expenses | -10,809 | -15,255 | -39,981 | -40,699 | -63,383 | |
| Personnel expenses | -13,844 | -12,574 | -46,814 | -39,432 | -54,201 | |
| Depreciation and impairment of tangible and intangible assets |
-2,302 | -1,380 | -6,205 | -3,983 | -5,261 | |
| Other operating expenses | -63 | -143 | -293 | -230 | -329 | |
| Operating profit/loss | 20,427 | 13,563 | 44,251 | 39,099 | 44,110 | |
| Operating margin | 33.5% | 24.7% | 25.2% | 24.8% | 20.7% |
| Adjusted operating profit and adjusted operating margin |
Jul - Sep | Jan - Sep | |||
|---|---|---|---|---|---|
| tSEK | 2023 | 2022 | 2023 | 2022 | 2022 |
| Operating profit/loss | 20,427 | 13,563 | 44,251 | 39,099 | 44,110 |
| Items affecting comparability | |||||
| Other external expenses | - | - | -381 | - | -2,802 |
| Personnel expenses | - | - | -4,450 | - | - |
| Total items affecting comparability | - | - | -4,831 | - | -2,802 |
| Adjusted operating profit/loss | 20,427 | 13,563 | 49,082 | 39,099 | 46,912 |
| Adjusted operating margin | 33.5% | 24.7% | 27.9% | 24.8% | 22.0% |
| ARPU | Jul - Sep | Jan - Sep | Jan - Dec | ||
|---|---|---|---|---|---|
| tSEK | 2023 | 2022 | 2023 | 2022 | 2022 |
| Subscription income | 60,908 | 54,716 | 175,272 | 157,046 | 212,534 |
| Number of subscriptions previous period (thousands) | 877 | 921 | 904 | 901 | 901 |
| Number of subscriptions current period (thousands) | 887 | 912 | 887 | 912 | 904 |
| ARPU (SEK) | 276 | 239 | 261 | 231 | 236 |
The Board of Directors and CEO assure that the interim report provides a fair and accurate overview of the operations, financial position and earnings of the parent company and group and describes significant risks and uncertainties that the parent company and the companies included in the group face.
Gothenburg, October 24, 2023
Anne Broeng Chairman of the Board
Rasmus Järborg Board member
Olof Nilsson Board member
Mathias Høyer Board member
Maciej Drejak Board member Per Andersson Acting CEO
We have reviewed the condensed interim financial information (interim report) of Sleep Cycle AB (publ) as of 30 September 2023 and the ninemonth period then ended. The board of directors and the CEO are responsible for the preparation and presentation of the interim financial information in accordance with IAS 34 and the Swedish Annual Accounts Act. Our responsibility is to express a conclusion on this interim report based on our review.
We conducted our review in accordance with the International Standard on Review Engagements ISRE 2410, Review of Interim Report Performed by the Independent Auditor of the Entity. A review consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing, ISA, and other generally accepted auditing standards in Sweden. The procedures performed in a review do not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review, nothing has come to our attention that causes us to believe that the interim report is not prepared, in all material respects, in accordance with IAS 34 and the Swedish Annual Accounts Act, regarding the Group, and with the Swedish Annual Accounts Act, regarding the Parent Company.
Gothenburg, 24 October 2023
Öhrlings PricewaterhouseCoopers AB
Ulrika Ramsvik Authorized Public Accountant
For more information, please contact:
PER ANDERSSON, ACTING CEO & CFO Tel: +46 70-939 53 27 Email: [email protected]
SLEEP CYCLE AB Business reg. No. 556614-7368, Drakegatan 10, 412 50 Gothenburg www.sleepcycle.com

SLEEP CYCLE – INTERIM REPORT JUL – SEP 2023 22
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.